DMC Biotechnologies successfully produces L-alanine at pilot scale

In Colorado, DMC Biotechnologies has successfully produced its lead product, L-alanine, at pilot scale. Commercial key performance metrics were achieved and performance from the bench scale was also demonstrated at 3m3scale fermentation and for each of the downstream purification unit operations.  The robustness of DMC’s Dynamic Metabolic Control technology to the process environment was also validated. The predictability of the DMC process has been demonstrated from high throughput screening to commercially relevant scale. Kilogram-sized samples of on-specification product are currently being provided to potential customers, paving the way to commercial launch later this year. No further strain improvement or process engineering is required.